P10 INC-A (PX) Stock Analyst Ratings
USA - NYSE:PX - US69376K1060 - Common Stock
10.45 USD
+0.03 (+0.29%)
10.45 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 82% to PX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.3. This target is 46.41% above the current price.
PX was analyzed by 13 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about PX.
In the previous month the buy percentage consensus was at a similar level.
PX was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-07-14 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-09 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-14 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-07 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-13 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2025-02-13 | Barclays | Maintains | Overweight -> Overweight |
| 2025-01-13 | Barclays | Maintains | Overweight -> Overweight |
| 2025-01-07 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2024-12-12 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-12-09 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-12 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-11-11 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2024-11-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-08 | Keefe, Bruyette & Woods | Reiterate | Market Perform -> Market Perform |
| 2024-10-22 | UBS | Maintains | Neutral -> Neutral |
| 2024-10-16 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-10 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-10-07 | Barclays | Maintains | Overweight -> Overweight |
| 2024-08-21 | UBS | Downgrade | Buy -> Neutral |
| 2024-08-14 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-08-12 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2024-08-12 | Barclays | Maintains | Overweight -> Overweight |
| 2024-08-12 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-08-09 | Keefe, Bruyette & Woods | Reiterate | Market Perform -> Market Perform |
| 2024-03-04 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-03-04 | Barclays | Maintains | Overweight -> Overweight |
| 2024-03-04 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-03-01 | Keefe, Bruyette & Woods | Downgrade | Outperform -> Market Perform |
P10 INC-A / PX FAQ
What is the average price target for P10 INC-A (PX) stock?
13 analysts have analysed PX and the average price target is 15.3 USD. This implies a price increase of 46.41% is expected in the next year compared to the current price of 10.45.
How do analysts rate P10 INC-A (PX)?
The consensus rating for P10 INC-A (PX) is 81.5385 / 100 . This indicates that analysts generally have a positive outlook on the stock.